WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 255,103 shares, an increase of 118.2% from the June 30th total of 116,931 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 144,071 shares, the short-interest ratio is presently 1.8 days.

WuXi Biologics (Cayman) Price Performance

OTCMKTS:WXXWY opened at $10.06 on Thursday. WuXi Biologics has a 1-year low of $7.27 and a 1-year high of $11.21. The business’s 50-day moving average price is $8.79 and its two-hundred day moving average price is $9.10.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.